EUVIMED · CrossrefJournal
Hepatology, Medicine and Policy
ISSN 2059-5166 · Springer Science and Business Media LLC
Latest articles
A new paradigm evaluating cost per cure of HCV infection in the UK
State of viral hepatitis knowledge and testing uptake in Brazil: Findings from the National Survey of Knowledge, Attitudes and Practices (PCAP-2013)
Hepatitis B knowledge among key stakeholders in Haimen City, China: Implications for addressing chronic HBV infection
Editor-in-Chief’s welcome to Hepatology, Medicine and Policy
A community- based hepatitis B linkage-to-care program: a case study on Asian Americans chronically infected with hepatitis B virus
Hepatitis B knowledge among women of childbearing age in three slums in Mumbai: a cross-sectional survey
Coverage of different health insurance programs and medical costs associated with chronic hepatitis C infection in mainland China: a cross-sectional survey in 20 provinces
Strengthening hepatitis B and C surveillance in Europe: results from the two global hepatitis policy surveys (2013 and 2014)
Predisposing, enabling, and need factors associated with utilization of HCV testing services among PWID in two settings in India
Urgent action to fight hepatitis C in people who inject drugs in Europe
National alliance for Wilson’s disease: health policy in Costa Rica
HMAP, World Hepatitis Day and the bigger health systems picture
Knowledge about hepatitis B and hepatitis C virus infection and consequences: a cross-sectional assessment of baseline knowledge among infected patients in West Bengal, India
Antiretroviral therapy and liver disease progression in HIV and hepatitis C co-infected patients: a systematic review and meta-analysis
Concordance between self-reported and measured HIV and hepatitis C virus infection status among people who inject drugs in Germany
HCV/HIV coinfection among people who inject drugs and enter opioid substitution treatment in Greece: prevalence and correlates
Roundtable discussion: how the World Hepatitis Summit 2015 strengthened stakeholders’ efforts to combat viral hepatitis
The hurdle with remaining risk for hepatocellular carcinoma in cirrhotic patients after a hepatitis C cure
Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg
The Berlin Hepatitis C Manifesto: access to prevention, testing, treatment and care for people who use drugs
Innovative sources for funding of viral hepatitis prevention and treatment in low- and middle-income countries: a roundtable meeting report
Responding to HBV and HCV in China and India: thematic series introduction
Incidence of hepatitis C among people who inject drugs in Ireland
Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and access
Hepatitis C in Eastern Europe and Central Asia: a survey of epidemiology, treatment access and civil society activity in eleven countries
A school-based intervention of screening a movie to increase hepatitis B vaccination levels among students in Uttar Pradesh, India: impact on knowledge, awareness, attitudes and vaccination levels
Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needs
Design of the Prospective Real-world Outcomes Study of hepatic encephalopathy Patients’ Experience on Rifaximin-α (PROSPER): an observational study among 550 patients
Uptake of hepatitis B-HIV co-infection screening and management in a resource limited setting
“B in IT” - a community-based model for the management of hepatitis B patients in primary care clinics using a novel web-based clinical tool
EUVIMED